Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
European Journal of Pharmacology|July 4, 1989
1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptakeE A Johnson, E Y Wu, H Rollema, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1982
Metabolism of phencyclidine. The role of iminium ion formation in covalent binding to rabbit microsomal proteinD P Ward, A J Trevor, A Kalir, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1975
Metabolic disposition and cardiovascular effects of methyldopate in unanesthetized rhesus monkeysP D Walson, K S Marshall, R P Forsyth, et al.
Chemical Research in Toxicology|May 23, 2001
Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobaccoK P Castagnoli, S J Steyn, J P Petzer, et al.
Biochemical and Biophysical Research Communications|December 26, 1991
Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidolB Subramanyam, S M Pond, D W Eyles, et al.
Chemical Research in Toxicology|May 1, 1994
Metabolic studies on haloperidol and its tetrahydropyridine analog in C57BL/6 miceC J Van der Schyf, K Castagnoli, E Usuki, et al.
Pharmacology|January 1, 1987
Pharmacokinetics and excretion of unique beta-adrenergic agonistsB L Ferraiolo, M M Halldin, Y Asscher, et al.
Experimental Neurology|August 17, 1999
Clinical and neuropathological abnormalities in baboons treated with HPTP, the tetrahydropyridine analog of haloperidolG M Halliday, S M Pond, H Cartwright, et al.
Pageof 16